Refine by
Human Epidermis Articles & Analysis
16 news found
Creative Enzymes, a renowned biotechnology company, has unveiled a groundbreaking product that is set to revolutionize the health and wellness industry. Yeast-Fermented Vegan Collagen is the latest innovation from Creative Enzymes, offering a sustainable and ethical alternative to traditional animal-derived collagen supplements. As a leading authority in enzyme research and biotechnological ...
XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide a product development report on its Rotigotine transdermal (“TDS”) patch. The Company’s Rotigotine patch is based on the TDS platform technology developed by its wholly owned German subsidiary, Vektor Pharma TF GmbH (“Vektor”). Over ...
The skin around these small spots immediately initiates a lateral repair mechanism, and the epidermis heals completely within 8 hours. In a few days or so, the scabs at the small white spots fall off and the skin returns to its normal appearance. ...
MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new in vitro kidney model. MatTek Life Sciences, a Boston-area tissue engineering company and a member of the BICO Group, announced today it has entered into a distribution agreement and strategic partnership with Cell4Pharma, a Netherlands-based company specializing ...
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it’s clinical advisory team has completed the primary design of the next-phase clinical study of its skin rejuvenation product, RCS-01, to be conducted as part of ...
BOSTON, Jan. 8, 2021 /PRNewswire-PRWeb/ -- DermBiont, a clinical-stage biotechnology company developing targeted topical therapeutics, announced today that its phase 2b clinical trial with its investigational drug product, DBI-001, for the treatment of tinea pedis resulted in statistically significant decreases in the abundance in T. rubrum, statistically significant improvement in the ...
BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. “This strategic acquisition delivers multi-factorial value,” said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. “It expands ...
Poietis, 4D Bioprinting company, announces formation of Scientific Advisory Board (SAB) and appointment of two first prominent Scientists in Regenerative Medicine. The SAB will serve as a key strategic resource to Poietis as the company expands capabilities of Next- Generation Bioprinting (NGB) platform to therapeutic applications and develops first implantable tissues such as a ...
ByPoietis
Medical polymer materials for the first time into the line of sight of people in 1949, is the first published the prospect of medical polymer materials, for the first time introduced the use of poly (methyl methacrylate as a person's skull, joint and femoral, using polyamide as the clinical application of surgical suture, since then, usher in rapid development of medical polymer materials, is ...
The warm and humid conditions in many parts of Puerto Rico and the Caribbean make for an ideal environment for dust mites. One of the most common causes of allergies to house dust is due to the presence of these tiny eight-legged creatures that are typically too small to see with the naked eye. Many homes and buildings have dust mites and a single gram of dust may have hundreds or more in ...
On January 27, 2014, the Federal Institute for Risk Assessment (BfR) posted frequently asked questions (FAQ) regarding the risk assessment of cosmetic products. BfR states that there are repeated critical public reports and discussions about several ingredients of cosmetic products, leading consumers to ask whether cosmetics pose a health risk. Several of the FAQs address nanomaterials: Why are ...
Lurking in ordinary house dust is one of the most common causes of allergies. Dust mites can be found in most homes and a single gram of house dust may have hundreds or even thousands of dust mites in it. Dust mites are tiny eight-legged creatures that feed on human skin scales that people shed as well as animal dander, fungi, bacteria and pollen. Because they absorb water from the air and their ...
Background -- Cosmetic Products The EC's summary of the recast states: "Cosmetic products are substances or mixtures of substances intended to be placed in contact with the external parts of the human body (epidermis, hair system, nails, etc.) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, ...
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate people about issues that may impact their health. Their latest educational video discusses health issues associated dust mites and their connection to indoor allergies and their ability to trigger asthma attacks. One of the most common causes of allergies to house dust is ...
The U.S. Environmental Protection Agency has issued legal complaints against two Brooklyn stores for violating federal pesticides law by selling and distributing illegal pesticides. Products used to kill pests must be registered with EPA to ensure that they will not make people sick and contain labels with instructions on their proper use. In September 2011, EPA inspections of two Brooklyn ...
An investigation conducted last week by the U.S. Environmental Protection Agency revealed that dangerous and illegal pesticides are widely available in New York City. Federal and state experts conducted 47 inspections and found 16 different types of illegal pesticides. The pesticides were not registered by EPA and consumers have no way of knowing how dangerous they are, because they were not ...